News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
173,778 Results
Type
Article (16884)
Company Profile (19)
Press Release (156875)
Section
Business (51824)
Career Advice (375)
Deals (8605)
Drug Delivery (47)
Drug Development (30546)
Employer Resources (38)
FDA (4714)
Job Trends (4551)
News (93685)
Policy (8388)
Tag
Academia (1022)
Alliances (12567)
Alzheimer's disease (933)
Antibody-drug conjugate (ADC) (53)
Approvals (4690)
Artificial intelligence (79)
Bankruptcy (58)
Best Places to Work (3706)
Breast cancer (136)
Cancer (894)
Cardiovascular disease (65)
Career advice (316)
CAR-T (72)
Cell therapy (162)
Clinical research (24528)
Collaboration (247)
COVID-19 (1354)
C-suite (77)
Data (774)
Diabetes (95)
Diagnostics (2880)
Drug pricing (45)
Earnings (20376)
Events (19898)
Executive appointments (245)
FDA (5085)
Funding (242)
Gene editing (49)
Gene therapy (131)
GLP-1 (322)
Government (1484)
Healthcare (5286)
Immunology and inflammation (56)
Infectious disease (1411)
Interviews (79)
IPO (4210)
Job creations (1041)
Job search strategy (256)
Layoffs (221)
Legal (1433)
Lung cancer (144)
Lymphoma (64)
Manufacturing (91)
Medical device (3186)
Medtech (3188)
Mergers & acquisitions (4522)
Metabolic disorders (278)
Neurodegenerative disease (48)
Neuroscience (1145)
NextGen: Class of 2025 (1609)
Non-profit (1377)
Northern California (779)
Obesity (165)
Opinion (123)
Parkinson's disease (60)
Patents (49)
People (15739)
Phase I (7712)
Phase II (10992)
Phase III (8673)
Pipeline (412)
Postmarket research (710)
Preclinical (2569)
Radiopharmaceuticals (101)
Rare diseases (143)
Real estate (1404)
Regulatory (6150)
Research institute (977)
Series A (54)
Southern California (600)
Startups (1461)
United States (6013)
Vaccines (321)
Weight loss (127)
Date
Last 7 days (257)
Last 30 days (878)
Last 365 days (11823)
2025 (1832)
2024 (11903)
2023 (13197)
2022 (16113)
2021 (16894)
2020 (15866)
2019 (12181)
2018 (9472)
2017 (9517)
2016 (8515)
2015 (9587)
2014 (6452)
2013 (4774)
2012 (5213)
2011 (5505)
2010 (4806)
Location
Africa (214)
Asia (10910)
Australia (2201)
California (1655)
Canada (505)
China (160)
Colorado (65)
Connecticut (62)
Europe (26660)
Florida (198)
Illinois (132)
Indiana (82)
Japan (52)
Maryland (189)
Massachusetts (1250)
Minnesota (55)
New Jersey (511)
New York (525)
North Carolina (180)
Northern California (779)
Pennsylvania (329)
South America (241)
Southern California (600)
Texas (297)
Utah (59)
Washington State (156)
173,778 Results for "earli".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Alzheimer’s disease
Vigil’s TREM2-Targeted Alzheimer’s Treatment Shows Early Promise, Moves On to Phase II
Vigil Neuroscience reported a strong safety profile and 50% sTREM2 reduction in an early-stage trial for VG-3927, potentially representing a new avenue for treating Alzheimer’s disease.
January 23, 2025
·
2 min read
·
Dan Samorodnitsky
Partnered
The Strategic Imperative: Why Early Potency Assay Development Makes or Breaks ATMP Success
Not developing potency assays and gaining knowledge about MOAs early in the drug development process not only can break ATMP success but can cause costs and delays that lead to company closures.
December 9, 2024
·
7 min read
·
BioSpace Insights
Obesity
AstraZeneca Bolsters Obesity Pipeline With Promising Early Data for Candidates
While expected and seen as largely incremental, Jefferies analyst Peter Welford in a Tuesday note to investors said the detailed data for three early-stage assets support moving them into Phase IIb studies and creates a “foothold” for AstraZeneca in the weight loss space.
November 5, 2024
·
3 min read
·
Tristan Manalac
Cancer
Arcus Challenges Merck in Kidney Cancer with Early Data
Casdatifan’s progression-free survival benefits could help differentiate it from Merck’s Welireg in the kidney cancer arena, according to analysts at Truist Securities.
February 18, 2025
·
2 min read
·
Tristan Manalac
Kidney cancer
Gilead Passes on Option for Arcus’ Cancer Drug Despite Strong Early Data
The news comes on the heels of promising Phase I/Ib data, which point to the potential of casdatifan as a more effective alternative to Merck’s Welireg in renal cell carcinoma.
February 19, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Alpheus Medical Publishes Promising Early Clinical Results of Sonodynamic Therapy for the Treatment of Newly Diagnosed Glioblastomas
February 26, 2025
·
2 min read
Press Releases
Dovetail Genomics Announces Early Access Service for FFPE Sample Analysis, Enhancing Cancer Research Capabilities
February 26, 2025
·
4 min read
Press Releases
Update on Regulatory Review of Lecanemab for Early Alzheimer’s Disease in the European Union
January 31, 2025
·
9 min read
Press Releases
Bioxodes secures new funds to reach early 2025 milestones and pursue Series B financing
February 12, 2025
·
4 min read
Press Releases
Sphere Fluidics Launches Cyto-Mine Chroma and Announces Early Access Program
January 27, 2025
·
2 min read
1 of 17,378
Next
